Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation

被引:79
作者
An, Hyun-Jung [2 ,3 ]
Kim, Young Jin [1 ]
Song, Dong Hyun [1 ]
Park, Beom Suk [1 ]
Kim, Ho Min [5 ]
Lee, Ju Dong [5 ]
Paik, Sang-Gi [2 ,3 ]
Lee, Jie-Oh [1 ,6 ]
Lee, Hayyoung [4 ]
机构
[1] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea
[2] Chungnam Natl Univ, Coll Biosci & Biotechnol, Dept Biol, Taejon 305764, South Korea
[3] Chungnam Natl Univ, Coll Biosci & Biotechnol, Daedeok R&D Innopolis Bio Brain Ctr BK21, Taejon 305764, South Korea
[4] Chungnam Natl Univ, Coll Biosci & Biotechnol, Inst Biotechnol, Taejon 305764, South Korea
[5] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Taejon 305701, South Korea
[6] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea
基金
新加坡国家研究基金会;
关键词
HUMAN CD40 LIGAND; X-LINKED IMMUNODEFICIENCY; HYPER-IGM SYNDROME; CRYSTAL-STRUCTURE; MOLECULAR-MODELS; FACTORS TRAFS; BINDING; DOMAIN; CELLS; GP39;
D O I
10.1074/jbc.M110.208215
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD40 is a tumor necrosis factor receptor (TNFR) family protein that plays an important role in B cell development. CD154/CD40L is the physiological ligand of CD40. We have determined the crystal structure of the CD40-CD154 complex at 3.5 angstrom resolution. The binding site of CD40 is located in a crevice formed between two CD154 subunits. Charge complementarity plays a critical role in the CD40-CD154 interaction. Some of the missense mutations found in hereditary hyper-IgM syndrome can be mapped to the CD40-CD154 interface. The CD40 interaction area of one of the CD154 subunits is twice as large as that of the other subunit forming the binding crevice. This is because cysteine-rich domain 3 (CRD3) of CD40 has a disulfide bridge in an unusual position that alters the direction of the ladder-like structure of CD40. The Ser(132) loop of CD154 is not involved in CD40 binding but its substitution significantly reduces p38- and ERK-dependent signaling by CD40, whereas JNK-dependent signaling is not affected. These findings suggest that ligand-induced di- or trimerization is necessary but not sufficient for complete activation of CD40.
引用
收藏
页码:11226 / 11235
页数:10
相关论文
共 48 条
[1]   PHENIX:: building new software for automated crystallographic structure determination [J].
Adams, PD ;
Grosse-Kunstleve, RW ;
Hung, LW ;
Ioerger, TR ;
McCoy, AJ ;
Moriarty, NW ;
Read, RJ ;
Sacchettini, JC ;
Sauter, NK ;
Terwilliger, TC .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2002, 58 :1948-1954
[2]   MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40 [J].
ARMITAGE, RJ ;
FANSLOW, WC ;
STROCKBINE, L ;
SATO, TA ;
CLIFFORD, KN ;
MACDUFF, BM ;
ANDERSON, DM ;
GIMPEL, SD ;
DAVISSMITH, T ;
MALISZEWSKI, CR ;
CLARK, EA ;
SMITH, CA ;
GRABSTEIN, KH ;
COSMAN, D ;
SPRIGGS, MK .
NATURE, 1992, 357 (6373) :80-82
[3]   THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].
ARUFFO, A ;
FARRINGTON, M ;
HOLLENBAUGH, D ;
LI, X ;
MILATOVICH, A ;
NONOYAMA, S ;
BAJORATH, J ;
GROSMAIRE, LS ;
STENKAMP, R ;
NEUBAUER, M ;
ROBERTS, RL ;
NOELLE, RJ ;
LEDBETTER, JA ;
FRANCKE, U ;
OCHS, HD .
CELL, 1993, 72 (02) :291-300
[4]   KNOWLEDGE-BASED MODEL-BUILDING OF PROTEINS - CONCEPTS AND EXAMPLES [J].
BAJORATH, J ;
STENKAMP, R ;
ARUFFO, A .
PROTEIN SCIENCE, 1993, 2 (11) :1798-1810
[5]   Detailed comparison of two molecular models of the human CD40 ligand with an x-ray structure and critical assessment of model-based mutagenesis and residue mapping studies [J].
Bajorath, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (38) :24603-24609
[6]  
Bajorath J, 1997, PROTEINS, V27, P59
[7]   ANALYSIS OF GP39/CD40 INTERACTIONS USING MOLECULAR-MODELS AND SITE-DIRECTED MUTAGENESIS [J].
BAJORATH, J ;
MARKEN, JS ;
CHALUPNY, NJ ;
SPOON, TL ;
SIADAK, AW ;
GORDON, M ;
NOELLE, RJ ;
HOLLENBAUGH, D ;
ARUFFO, A .
BIOCHEMISTRY, 1995, 34 (31) :9884-9892
[8]   IDENTIFICATION OF RESIDUES ON CD40 AND ITS LIGAND WHICH ARE CRITICAL FOR THE RECEPTOR-LIGAND INTERACTION [J].
BAJORATH, J ;
CHALUPNY, NJ ;
MARKEN, JS ;
SIADAK, AW ;
SKONIER, J ;
GORDON, M ;
HOLLENBAUGH, D ;
NOELLE, RJ ;
OCHS, HD ;
ARUFFO, A .
BIOCHEMISTRY, 1995, 34 (06) :1833-1844
[9]  
Bajorath J, 1996, PROTEIN SCI, V5, P531
[10]   CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION [J].
BANNER, DW ;
DARCY, A ;
JANES, W ;
GENTZ, R ;
SCHOENFELD, HJ ;
BROGER, C ;
LOETSCHER, H ;
LESSLAUER, W .
CELL, 1993, 73 (03) :431-445